Gastric or Gastroesophageal Junction Adenocarcinoma trials recruiting in Pennsylvania

Fewer than 3 recruiting trials found.

All Gastric or Gastroesophageal Junction Adenocarcinoma trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
  NCT05482893 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh